AptaTeck Bio · raw details

Immuno-diagnostic Assays · Jerusalem · Founded 2009

inactive Pre-Funding ← back to profile

About

Immuno-diagnostic Assays

AptaTeck Bio has developed a proprietary technology based on an amplification probe for developing highly sensitive immuno-assays employing both antibodies and aptamers. AptaTeck's signal amplification technology is designed to generate specific, highly sensitive, accurate, and reproducible immune diagnostics assays. It is compatible with a variety of platforms, automated and manual, and could be integrated easily into most current commercial platforms. The system is demonstrated in ELISA assays and flow cytometry. The AptaTeck system is cost effective and enables accurate diagnosis at the point of care. AptaTeck's technology is suitable for the detection of a variety of target molecules including biomarkers, viral and bacterial antigens, nucleic acids, cell surface, and soluble antigens.

Identity

NameAptaTeck Bio
Slugaptateck
Type / kindstartup
Crunchbase IDaptateck-bio
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoN6gpdYJDA

Status

Statusinactive
Status reasonNon Active, Jan 2015 ceased to operate
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtJerusalem District
HQ cityJerusalem
HQ addressSderot Golda Me'ir 7, Jerusalem, Israel

Web & social

Websitehttps://www.aptateck.com

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
targeted-cancer-therapyantibodiescancer-researchimmunologypharmaceuticals

Funding

Total raised
Current stagePre-Funding

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}